NDC 43742-1159

HypoGlycemx

Aceticum Acidum, Cacao, Magnesia Sulphurica, Natrum Sulphuricum, Verbascum Thapsus, Glandula Suprarenalis Suis, Pancreas Suis, Cortisone Aceticum, Thyroidinum (suis), Iodium, Lycopodium Clavatum, Phosphorus, Ranunculus Bulbosus, Saccharum Officinale, Vanadium Metallicum, Chromium Acidum, Culex Musca

HypoGlycemx is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Deseret Biologicals, Inc. The primary component is Acetic Acid; Cocoa; Magnesium Sulfate Heptahydrate; Sodium Sulfate; Verbascum Thapsus; Sus Scrofa Adrenal Gland; Sus Scrofa Pancreas; Cortisone Acetate; Thyroid, Porcine; Iodine; Lycopodium Clavatum Spore; Phosphorus; Ranunculus Bulbosus; Sucrose; Vanadium; Zinc; Chromium Trioxide; Culex Pipiens.

Product ID43742-1159_947d789b-3622-4e63-ba21-b9064759babd
NDC43742-1159
Product TypeHuman Otc Drug
Proprietary NameHypoGlycemx
Generic NameAceticum Acidum, Cacao, Magnesia Sulphurica, Natrum Sulphuricum, Verbascum Thapsus, Glandula Suprarenalis Suis, Pancreas Suis, Cortisone Aceticum, Thyroidinum (suis), Iodium, Lycopodium Clavatum, Phosphorus, Ranunculus Bulbosus, Saccharum Officinale, Vanadium Metallicum, Chromium Acidum, Culex Musca
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date2018-02-21
Marketing End Date2023-02-26
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameDeseret Biologicals, Inc
Substance NameACETIC ACID; COCOA; MAGNESIUM SULFATE HEPTAHYDRATE; SODIUM SULFATE; VERBASCUM THAPSUS; SUS SCROFA ADRENAL GLAND; SUS SCROFA PANCREAS; CORTISONE ACETATE; THYROID, PORCINE; IODINE; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; RANUNCULUS BULBOSUS; SUCROSE; VANADIUM; ZINC; CHROMIUM TRIOXIDE; CULEX PIPIENS
Active Ingredient Strength3 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
NDC Exclude FlagN

Packaging

NDC 43742-1159-1

30 mL in 1 BOTTLE, DROPPER (43742-1159-1)
Marketing Start Date2018-02-21
Marketing End Date2023-02-26
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 43742-1159-1 [43742115901]

HypoGlycemx LIQUID
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-02-21
Marketing End Date2023-02-26

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.